FDA panel recommends CRT-D for mildy symptomatic HF patients
Cardiovascular Business
7 in a three-to-two vote that the overall clinical benefits of Medtronic's cardiac resynchronization therapy with implantable cardioverter-defibrillator (CRT-D) devices outweigh the risks in treating certain mildly symptomatic heart failure (HF) ...
FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac ...MarketWatch (press release)
FDA Panel Recommends Expanding Medtronic Heart Device UseWall Street Journal (India)
Medtronic Defibrillators Win FDA Panel Backing for Wider UseBusinessWeek
all 15 news articles »